Cite
HARVARD Citation
Sullivan, R. (2016). Serum lactate dehydrogenase is a more useful biomarker of prognosis than serum S100B in patients with BRAF‐mutant melanoma. British journal of dermatology. pp. 716-717. [Online].
This is an interim version of our Electronic Legal Deposit Catalogue-eJournals and eBooks while we continue to recover from a cyber-attack.
Sullivan, R. (2016). Serum lactate dehydrogenase is a more useful biomarker of prognosis than serum S100B in patients with BRAF‐mutant melanoma. British journal of dermatology. pp. 716-717. [Online].